Home
About
Overview
Sharing Data
ORCID
Help
History (1)
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy.
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy. J Clin Invest. 2019 02 25; 129(4):1551-1565.
View in:
PubMed
subject areas
Adoptive Transfer
Animals
Fas Ligand Protein
fas Receptor
Fas-Associated Death Domain Protein
Female
Genetic Engineering
Humans
Male
Mice
Mice, Transgenic
Neoplasms, Experimental
Signal Transduction
Tumor Microenvironment
authors with profiles
Jeffrey E. Hammerbacher
Bulent Aksoy